Genetic

Canna Green

Genetic

Stability and quality control

In the CannaGreen project, we apply modern biotechnology to ensure stable yields, high CBD content, low THC (<0.3%) and compliance with European standards.

Basic technologies

Tissue Culture (microcloning)

Each plant is genetically identical, sterile, and virus-free, ensuring consistent yields and reducing risks.

CRISPR/Cas9

Genetic editing to eliminate unstable DNA regions, increase disease resistance and CBD/THC stability.

Marker-Assisted Selection (MAS)

Early-stage plant DNA analysis — selection of the best genetic lines even before cultivation.

Haploid technologies

Rapid creation of stable hybrids with specified characteristics.

🧪Genetic control

Continuous laboratory monitoring of CBD/THC

Mutation and virus testing (TMV, HpLV)

Cooperation with scientific institutions in Ukraine and the EU

🤝 Partner laboratories

Institute of Cell Biology of the National Academy of Sciences of Ukraine

CBD Test Lab (Germany)

``Agrobiotech Ukraine``

`` Phytoplant Research ``(Spain)

Benefits for the investor

Higher yield, lower losses

Uniform product quality — better selling price

GMP / ISO / EU compliance

Minimizing the risks of crop failure

[gtranslate]